COMPASS PATHWAYS PLC (CMPS) ROI
- 2026-06-30: ROI -291.43%.
- 2026-03-31: ROI -47.41%.
- 2025-12-31: ROI 1356.88%.
- 2025-09-30: ROI -344.64%.
Complete source-backed roi history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | -291.43% |
| 2026-03-31 | -47.41% |
| 2025-12-31 | 1356.88% |
| 2025-09-30 | -344.64% |
| 2025-06-30 | -71.37% |
| 2025-03-31 | -60.97% |
| 2024-12-31 | -83.91% |
| 2023-12-31 | -46.55% |
Annual ROI
| Date | ROI |
|---|---|
| 2025-12-31 | 1356.88% |
| 2024-12-31 | -83.91% |
| 2023-12-31 | -46.55% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |